<?xml version="1.0" encoding="UTF-8"?>
<results title="zoonosis">
 <result pre="interferon IL interleukin M membrane protein mAbs monoclonal Abs MERS" exact="Middle East respiratory syndrome" post="MoA mode of action N nucleoprotein nsp nonstructural protein"/>
 <result pre="pathologies. On the other hand, the emergence of SARSâ€�CoV and" exact="Middle East respiratory syndrome" post="coronavirus (MERSâ€�CoV) has led to a growing number of"/>
 <result pre="also an option.24 This approach was used in the latest" exact="Ebola" post="outbreak and led to the development of ZMapp.25 Neutralizing"/>
 <result pre="the other hand, molecules such as remdesivir, initially developed against" exact="Ebola" post="virus,45 appear to have an inhibitory effect against SARSâ€�CoV"/>
 <result pre="activity, with antiviral effects against flaviviruses,74, 75 alphaviruses,76 noroviruses,77 and" exact="Ebola" post="virus.78, 79, 80 Favipiravir was approved for influenza treatment"/>
 <result pre="J. 2005;170(2):193â€�211.16129340 25HoenenT, GrosethA, FeldmannH. Therapeutic strategies to target the" exact="Ebola" post="virus life cycle. Nat Rev Microbiol. 2019;17(10):593â€�606.31341272 26WangL, ShiW,"/>
 <result pre="of neutralizing monoclonal antibodies targeting multiple antigenic sites on the" exact="Middle East respiratory syndrome" post="coronavirus spike glycoprotein to avoid neutralization escape. J Virol."/>
 <result pre="et al. Therapeutic efficacy of the small molecule GSâ€�5734 against" exact="Ebola" post="virus in rhesus monkeys. Nature. 2016;531(7594):381â€�385.26934220 46AgostiniML, AndresEL, SimsAC,"/>
 <result pre="57BhatnagarT, MurhekarMV, SonejaM, et al. Lopinavir/ritonavir combination therapy amongst symptomatic" exact="coronavirus disease 2019" post="patients in India: protocol for restricted public health emergency"/>
 <result pre="of an FDAâ€�approved compound library identifies four smallâ€�molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell culture. Antimicrob Agents Chemother. 2014;58(8):4875â€�4884.24841269"/>
 <result pre="78GuedjJ, PiorkowskiG, JacquotF, et al. Antiviral efficacy of favipiravir against" exact="Ebola" post="virus: a translational study in cynomolgus macaques. PLoS Med.2018;15(3):e1002535.29584730"/>
 <result pre="79OestereichL, LÃ¼dtkeA, WurrS, RiegerT, MuÃ±ozâ€�FontelaC, GÃ¼ntherS. Successful treatment of advanced" exact="Ebola" post="virus infection with Tâ€�705 (favipiravir) in a small animal"/>
 <result pre="LenkRP, LeverMS. Postâ€�exposure efficacy of oral Tâ€�705 (favipiravir) against inhalational" exact="Ebola" post="virus infection in a mouse model. Antiviral Res. 2014;104:153â€�155.24462697"/>
 <result pre="dosing regimens. Biotechnol Biotechnol Equip. 2020;34(1):469â€&quot;474. 10.1101/2020.04.11.20061804. 123GubarevaLV, KaiserL, HaydenFG." exact="Influenza" post="virus neuraminidase inhibitors. Lancet. 2000;355(9206):827â€�835.10711940"/>
</results>
